Four pharma companies chimed in among the 146 official comments on the federal government's plan to tag pharma TV ads with drug prices. Pfizer, Eli Lilly, Sanofi and Johnson & Johnson filed commentary, along with the industry's leading trade association, PhRMA, during the 60-day period that ended in December.